Temple University
Temple University is a comprehensive public research university with 17 schools and colleges and 39,000 students. Temple is the 25th largest university in the United States and is one of the nation’s leading centers of professional education (law, dentistry, medicine, pharmacy, and podiatric medicine). With more than $130 million in external funding to support advanced research by its scholars, scientists and students, Temple is actively working to commercialize new discoveries through corporate partnerships and new startup companies.
Temple discoveries in the marketplace include sustained drug delivery technology for nutraceuticals and pharmaceuticals, diagnostic tests for chronic fatigue syndrome, instruments for the diagnosis and treatment of tooth decay, and pheromone attractant technology for pest control. Products in the pipeline include treatments for ocular disorders, diagnostics and therapeutics for cancer, devices to increase fuel economy and reduce emissions, and technology to treat severe lung disorders.
Through continued advancement of the university’s research enterprise, Temple is ensuring its place as a nexus of discovery, education, translational research and service, dedicated to improving quality of life and expanding our understanding of the world for the benefit of society.
Innovations (102):
- SOLID POLYMER ELECTROLYTE COMPOSITION (SPEC) LITHIUM ION BATTERY (17 MAY 13)
- Development of a therapeutically-useful bacterial virus for the treatment of antibiotic-resistant Enterococcus faecalis infections (17 MAY 13)
- A Tactile Imaging Sensor to Detect Breast Tumors (17 MAY 13)
- The Disulfide Isomerase ERp57 Mediates Platelet Aggregation (05 MAR 12)
- Plastic-Based Cementitious Materials (05 MAR 12)
- Linear Assemblies, Macrocycles and Covalent Bundles of Functionalized Bis-Peptides (05 MAR 12)
- Femtosecond Laser Vaporation Device for Disease Diagnosis and Explosive and Bio-threat Detection (05 AUG 11)
- Diagnostic Kit to Improve the Success of Assisted Reproduction (05 AUG 11)
- Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof (05 AUG 11)
- Biomarker for HIV-1 Infection (05 AUG 11)
Find more innovations
